PMEL and neoplasm: The melanocytic origin of tumors arising in both the Dct::TVA mouse models has previously been established using IHC for S100, HMB-45 and MART-1.33 The melanocytic origin of the MEK tumor cohorts was again confirmed by immunostaining for S100.